These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2876649)

  • 21. Addition of lithium to neuroleptic treatment in chronic schizophrenia.
    Lewis HA; Bacher NM; Field PB
    Am J Psychiatry; 1986 Feb; 143(2):262. PubMed ID: 2868667
    [No Abstract]   [Full Text] [Related]  

  • 22. Trials of adjunctive alprazolam in "negative symptom" patients.
    Adan F; Siris SG
    Can J Psychiatry; 1989 May; 34(4):326-8. PubMed ID: 2736478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of schizophrenic patients to benzodiazepines.
    Dreher GK
    Am J Psychiatry; 1992 Mar; 149(3):421-2. PubMed ID: 1599542
    [No Abstract]   [Full Text] [Related]  

  • 25. Emerging uses for high-potency benzodiazepines in psychotic disorders.
    Bodkin JA
    J Clin Psychiatry; 1990 May; 51 Suppl():41-6; discussion 50-3. PubMed ID: 1970817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia: recent advances in psychopharmacology.
    Sharma T
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):194-8. PubMed ID: 8777500
    [No Abstract]   [Full Text] [Related]  

  • 28. Treating depression in schizophrenia.
    Lund BC; Perry PJ; Miller DD
    Am J Psychiatry; 2001 Sep; 158(9):1528-9. PubMed ID: 11532750
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of schizophrenia. The Expert Consensus Panel for Schizophrenia.
    J Clin Psychiatry; 1996; 57 Suppl 12B():3-58. PubMed ID: 8946807
    [No Abstract]   [Full Text] [Related]  

  • 30. Important steps in the development of cognitive-enhancing drugs in schizophrenia.
    Buchanan RW
    Am J Psychiatry; 2006 Nov; 163(11):1867-9. PubMed ID: 17074932
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical trials during the prodromal stage of schizophrenia.
    Addington J; Addington D
    Am J Psychiatry; 2005 Jul; 162(7):1387. PubMed ID: 15994732
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjunctive clonazepam in the treatment of chronic schizophrenia.
    Herrera JM; Alvarez WA; Freinhar JP; Lawson WB; Sramek JJ
    Int J Psychosom; 1991; 38(1-4):17-20. PubMed ID: 1685726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unmet therapeutic needs.
    Carpenter W
    Schizophr Bull; 2005 Oct; 31(4):793-4. PubMed ID: 16166605
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neuroleptic modification of basic schizophrenic disorders].
    Heim M; Morgner J
    Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors which can make patients difficult to treat.
    Kane JM
    Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment-resistant schizophrenia - biological treatments].
    Hasan A; Wobrock T
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):464-71; quiz 472. PubMed ID: 23939560
    [No Abstract]   [Full Text] [Related]  

  • 38. Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients.
    Rapaport MH; Wolkowitz O; Kelsoe JR; Pato C; Konicki PE; Pickar D
    Neuropsychopharmacology; 1993 Sep; 9(2):111-5. PubMed ID: 8105790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.
    Simhandl C; Meszaros K
    J Psychiatry Neurosci; 1992 Mar; 17(1):1-14. PubMed ID: 1349823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.